Q2 2021 Financial Highlights: Total net revenue was $16.1 million Gross margin was 56% Completed $137.5 million financing transaction, extending...
Culver City, Calif. – August 2, 2021 — NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses...
Q1 2021 Financial Highlights: Total net revenue was $16.2 million, nearly all of which was software-related revenue Gross margin was...
Culver City, Calif. – May 4, 2021 — NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses...
Q4 Financial Highlights 2020 vs 2019: Total revenue was $18.6 million Total software-related revenue was $18.6 million, up from $18.4 million...
Culver City, Calif. – February 22, 2021 — NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses...
Q3 2020 Financial Highlights: Total net revenue was $18.8 million, up from $18.6 million Total software-related revenue increased to $18.7...
Culver City, Calif. – October 30, 2020 — NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses...
Q2 Financial Highlights 2020 vs 2019: SaaS revenue of $17.5 million vs $18.3 million Total gross margin of 58%, up...
Culver City, Calif. – August 3, 2020 — NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced...
Q1 Financial Highlights 2020 vs 2019: SaaS revenue was $18.1 million, up 2% Total gross margin increased to 60% from...
CULVER CITY, Calif.–(BUSINESS WIRE)–May 4, 2020– NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report...
